Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The noradrenergic locus coeruleus is a major wakefulness-promoting nucleus of the brain, which is also involved in the regulation of autonomic and endocrine functions. The activity of the locus coeruleus is believed to be tonically enhanced by a mesocoerulear dopaminergic pathway arising from the ventral tegmental area of the midbrain. Both modafinil, a wakefulness-promoting drug, and pramipexole, a D 2/D 3 receptor agonist with sedative properties, may act on this pathway, with modafinil increasing and pramipexole decreasing locus coeruleus activity. The aim of this study was to compare the two drugs on alertness, autonomic and endocrine functions in healthy volunteers. Pramipexole (0.5mg), modafinil (200mg), and their combination were administered to 16 healthy males in a double-blind, placebo-controlled design. Methods included tests of alertness (pupillographic sleepiness test, critical flicker fusion frequency, visual analogue scales), autonomic functions (resting pupil diameter, light and darkness reflex responses, heart rate, blood pressure, salivation, core temperature), and endocrine functions (blood concentrations of prolactin, growth hormone, and thyroid stimulating hormone). Data were analysed by ANOVA. Pramipexole reduced alertness, caused pupil dilatation, increased heart rate, reduced prolactin and thyroid stimulating hormone, and increased growth hormone level. Modafinil caused small increases in blood pressure and core temperature, and reduced prolactin levels. The sedative effect of pramipexole and the autonomic effects of modafinil are consistent with altered activity in the mesocoerulear pathway; the pupil dilatation following pramipexole suggests reduced dopaminergic excitation of the Edinger-Westphal nucleus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972
Swanson, L. W. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90145-9 · Cited by 1,718
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Dopamine as a Prolactin (PRL) Inhibitor
Ben-Jonathan, N., & Hnasko, R. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0451 · Cited by 983 · cited 2×
“In the present experiment, pramipexole, like other D2 dopamine receptor agonists (Svet-Moldovsky et al., 1981; Ben-Jonathan and Hnasko, 2001), decreased the concentration of prolactin in the blood in agreement with a previous report (Schilling et al.”
ResultModafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea
PACK, A. I., BLACK, J. E., SCHWARTZ, J. R. L., & MATHESON, J. K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103032 · Cited by 324
Daytime variations in central nervous system activation measured by a pupillographic sleepiness test
Wilhelm, B., Giedke, H., Lüdtke, H., Bittner, E., Hofmann, A., & Wilhelm, H. (2001) · Journal of Sleep Research · doi:10.1046/j.1365-2869.2001.00239.x · Cited by 167 · cited 1×
“Therefore, an increase in PUI relates to an increase in pupil fluctuation and an increase in sedation (Wilhelm et al., 2001).”
BackgroundSteady‐State Pharmacokinetic Properties of Pramipexole in Healthy Volunteers
Wright, C. E., Sisson, T. L., Ichhpurani, A. K., & Peters, G. R. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04330.x · Cited by 117
BRUN, J., CHAMBA, G., KHALFALLAH, Y., GIRARD, P., BOISSY, I., BASTUJI, H., SASSOLAS, G., & CLAUSTRAT, B. (1998) · Journal of Sleep Research · doi:10.1046/j.1365-2869.1998.00100.x · Cited by 85
Abduljawad, K. A. J., Langley, R. W., Bradshaw, C. M., & Szabadi, E. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100110 · Cited by 68
Self-citationModafinil elicits sympathomedullary activation
Taneja, I., Diedrich, A., Black, B. K., Byrne, D. W., Paranjape, S. Y., & Robertson, D. (2005) · Hypertension · doi:10.1161/01.hyp.0000158267.66763.63 · Cited by 68 · cited 2×
“The pressor effect of modafinil has been attributed to central sympathetic activation (Taneja et al., 2005).”
Background
Cited by
Samuels, E., & Szabadi, E. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777229 · Cited by 764
Self-citationModafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713
“In a study of healthy adults, single-dose modafinil 200 mg caused a reduction in blood prolactin levels; however, unlike the D2/D3 agonist pramipexole, it had no effect on blood growth hormone or thyroid stimulating hormone in these subjects (Samuels et al, 2006).”
BackgroundMapping anhedonia onto reinforcement learning: a behavioural meta-analysis
Huys, Q. J., Pizzagalli, D. A., Bogdan, R., & Dayan, P. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-12 · Cited by 480
Samuels, E., & Szabadi, E. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777193 · Cited by 454
Self-citationFunctional neuroanatomy of the central noradrenergic system
Szabadi, E. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113490326 · Cited by 335
Self-citation
Metadata
- Authors
- Samuels, E. R., Hou, R. H., Langley, R. W., Szabadi, E., & Bradshaw, C. M.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2006-11
- Volume
- 20
- Issue
- 6
- Pages
- 756-770
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1981929571
- Cited by
- 47
- References
- 11
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers. https://app.cochat.ai/papers/10.1177/0269881106060770
- The paper
- Samuels, E. R., Hou, R. H., Langley, R. W., Szabadi, E., & Bradshaw, C. M. (2006). Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers. Journal of Psychopharmacology. https://doi.org/10.1177/0269881106060770
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.